BioPharma
- Current Portfolio
- Past Portfolio
Devices / Diagnostics
HBM Pulse Subscribe
First Name /
Last Name*
E-Mail*
Company / Organization*
Security code
Please insert the code you see below.
Reset
Subscribe
News
PTC licenses Spinal Muscular Atrophy programme to Roche
(12 KB)
Ellipse receives award for best new technology in spine care
(29 KB)
Probiodrug announces top-line results of the first clinical study of PQ912 for treatment of Alzheimer's disease
(44 KB)
Archive
M&A Report
HBM Pharma/Biotech M&A Report
Links
HBM BioVentures
Subscribe To Our Newsletter
Subscribe here
Search
Search term
TOP
|
SITEMAP
|
CREDITS
|
IMPORTANT LEGAL INFORMATION
http://www.hbmpartners.com/en/newsletter/index.php
© HBM Partners AG 23.02.2012